がん研究を標的型療法に変換する
1The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK. johann.de-bono@icr.ac.uk
Nature
|October 1, 2010
まとめ
ガン治療薬の開発は,標的型療法へと移行しているが,依然として遅い. 将来の進歩は,パーソナライズされた医療のための統合研究とバイオマーカー駆動の臨床試験に依存しています.
科学分野:
- 腫瘍学 腫瘍学
- 薬理学 薬理学とは
- バイオテクノロジー バイオテクノロジー
背景:
- 伝統的な化学療法は,標的型がん薬によって置き換えられています.
- 進歩にもかかわらず,がん薬の開発は長く非効率的なプロセスです.
研究 の 目的:
- 現在のがん薬の開発における課題を特定する.
- 薬剤開発パイプラインの改善と加速のための戦略を提案する.
主な方法:
- 癌薬の開発における現在の動向の見直し.
- プロセスを妨げている問題の分析.
- 統合研究と適応的な臨床試験設計の提案.
主要な成果:
- 分子標的薬への移行は,有効性と副作用の減少の見込みを示しています.
- 患者さんへ新しいがん薬の提供には,依然として大きな遅れが続いています.
結論:
- 統合されたがん研究とバイオマーカー駆動の適応試験は極めて重要です.
- パーソナライズされたがん医学は,患者と腫瘍の遺伝学と生物学を深く理解する必要があります.
関連する概念動画
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...